【摘要】： 目的：對本實(shí)驗(yàn)室建立的人鼻咽癌紫杉醇耐藥細(xì)胞株(CNE-1/Taxol、HNE-2/Taxol)的生物學(xué)特性進(jìn)行觀察,檢測這兩株細(xì)胞系是否具有多藥耐藥性以及常見多藥耐藥基因MDR-1的表達(dá)情況。 方法：采用大劑量沖擊和逐步增加劑量相結(jié)合的方法,建立了兩株鼻咽癌紫杉醇耐藥細(xì)胞株(CNE-1/Taxol、HNE-2/Taxol),分別比較了這兩株耐藥細(xì)胞與其親本細(xì)胞的形態(tài)、生長曲線、倍增時(shí)間的差異；運(yùn)用流式細(xì)胞儀檢測了其細(xì)胞周期變化；集落形成實(shí)驗(yàn)檢測了它們對紫杉醇、順鉑、5-氟尿嘧啶、甲氨蝶呤和博來霉素五種化療藥的敏感性；使用real time RT-PCR比較了親本細(xì)胞與耐藥細(xì)胞MDR-1表達(dá)差異。 結(jié)果：兩株細(xì)胞系CNE-1/Taxol和HNE-2/Taxol的細(xì)胞大小及形態(tài)與親本細(xì)胞不一致,增殖速度減慢,倍增期延長,G2／M期細(xì)胞比例增多。集落形成實(shí)驗(yàn)結(jié)果顯示CNE-1/Taxol、HNE-2/Taxol對紫杉醇的敏感性顯著低于其親本細(xì)胞CNE-1和HNE-2,前兩者的IC50值分別為9.59±0.26、7.62±0.21,而后兩者的IC50分別為1.14±0.08、0.92±0.08；同時(shí),CNE-1/Taxol、HNE-2/Taxol對5-氟尿嘧啶和甲氨蝶呤的敏感性也顯著低于其親本細(xì)胞CNE-1和HNE-2,但耐藥指數(shù)顯著低于對紫杉醇的敏感性。然而,CNE-1/Taxol、HNE-2/Taxol對順鉑的敏感性顯著高于其親本細(xì)胞CNE-1和HNE-2,前兩者的IC50值分別為95.4±9.2、158.3±5.6,后兩者的IC50值分別為239.2±10.7、187.6±4.5；與親本細(xì)胞系比較,耐藥細(xì)胞系對博萊霉素的敏感性沒有變化(p0.05)；定量RT-PCR的結(jié)果顯示MDR-1在兩株親本細(xì)胞中表達(dá)均很低,且在耐藥細(xì)胞中表達(dá)無明顯增高,反而降低。 結(jié)論：CNE-1/Taxol、HNE-2/Taxol是兩株對紫杉醇耐藥的細(xì)胞株,是研究紫杉醇耐藥機(jī)制的重要實(shí)驗(yàn)?zāi)Ｐ停粌芍昴退幖?xì)胞對5-氟尿嘧啶、甲氨蝶呤產(chǎn)生了耐藥,具有多藥耐藥性的特點(diǎn)；紫杉醇耐藥細(xì)胞系對順鉑的敏感性更高；MDR-1在鼻咽癌細(xì)胞產(chǎn)生獲得性紫杉醇耐藥的過程中不起主要作用。
[Abstract]:Objective: to observe the biological characteristics of paclitaxel resistant human nasopharyngeal carcinoma cell line (CNE-1/Taxol,HNE-2/Taxol) established in our laboratory. To detect whether the two cell lines have multidrug resistance and the expression of common multidrug resistance gene MDR-1. Methods: two taxol resistant nasopharyngeal carcinoma cell lines (CNE-1/Taxol,HNE-2/Taxol) were established by the combination of high dose shock and stepwise increasing dose, and the morphology of these two cell lines were compared with those of their parents. Growth curve, difference of doubling time; The cell cycle changes were detected by flow cytometry, and the sensitivity to five chemotherapeutic agents, paclitaxel, cisplatin, 5-fluorouracil, methotrexate and bleomycin, were detected by colony forming assay. Real time RT-PCR was used to compare the difference of MDR-1 expression between parent cells and drug resistant cells. Results: the cell size and morphology of the two cell lines CNE-1/Taxol and HNE-2/Taxol were different from those of their parents, the proliferation rate was slow, the multiplication period was prolonged, and the proportion of G2 / M phase cells was increased. The results of colony formation test showed that the sensitivity of CNE-1/Taxol,HNE-2/Taxol to paclitaxel was significantly lower than that of CNE-1 and HNE-2, which were 9.59 鹵0.267.62 鹵0.21, respectively. The IC50 of the latter two was 1.14 鹵0.08 鹵0.92 鹵0.08; Meanwhile, the sensitivity of CNE-1/Taxol,HNE-2/Taxol to 5-fluorouracil and methotrexate was significantly lower than that of CNE-1 and HNE-2, but the drug resistance index was significantly lower than that of paclitaxel. However, the sensitivity of CNE-1/Taxol,HNE-2/Taxol to cisplatin was significantly higher than that of CNE-1 and HNE-2, (95.4 鹵9.158.3 鹵5.6) and IC50 (239.2 鹵10.7187.6 鹵4.5) respectively. Compared with parent cell line, the sensitivity of drug resistant cell line to bleomycin did not change (p0.05). The results of quantitative RT-PCR showed that the expression of MDR-1 in both parent cells was very low, and the expression of MDR-1 in resistant cells was not significantly increased, but decreased. Conclusion: CNE-1/Taxol,HNE-2/Taxol is two taxol resistant cell lines and is an important experimental model for studying the mechanism of paclitaxel resistance. Two drug-resistant cell lines developed resistance to 5-fluorouracil and methotrexate with multidrug resistance, and paclitaxel resistant cell lines were more sensitive to cisplatin. MDR-1 does not play a major role in the production of acquired paclitaxel resistance in nasopharyngeal carcinoma cells.
【學(xué)位授予單位】：中南大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2010
【分類號】：R739.63

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 ;Suppression of bcl-2 Gene by RNA Interference Increases Chemosensitivity to Cisplatin in Nasopharyngeal Carcinoma Cell Line CNE1[J];Acta Biochimica et Biophysica Sinica;2004年11期

2 章小平,楊紅枚,魯功成,李文鑫,劉輝;三種細(xì)胞因子對惡性腫瘤多藥耐受影響的實(shí)驗(yàn)研究[J];同濟(jì)醫(yī)科大學(xué)學(xué)報(bào);2000年05期

3 崔竹梅,向陽,楊秀玉,劉芝華;絨癌耐藥細(xì)胞系的建立及獲得性耐藥機(jī)制的研究[J];現(xiàn)代婦產(chǎn)科進(jìn)展;2001年05期

4 劉勤江;紅霉素逆轉(zhuǎn)頭頸腫瘤多藥耐藥的臨床研究[J];腫瘤學(xué)雜志;2001年05期

5 褚玉敏;譚國林;馬艷紅;;人鼻咽癌紫杉醇耐藥細(xì)胞株CNE-1/Taxol的建立及其機(jī)制初探[J];中國耳鼻咽喉顱底外科雜志;2007年06期

6 蔡鵬，劉敘儀，韓復(fù)生，，王萍;耐順鉑人肺腺癌細(xì)胞系A(chǔ)_（549）DDP的建立及耐藥機(jī)制[J];中國腫瘤臨床;1995年08期

7 欒英姿,李力,黎丹戎,張瑋,唐步堅(jiān);五種卵巢癌耐藥細(xì)胞系的建立及其部分耐藥相關(guān)基因的表達(dá)[J];中華婦產(chǎn)科雜志;2004年06期

8 劉宇,張幸平,陳曉品,陳鴻雁,徐曼,李圓圓;P糖蛋白在鼻咽癌放射治療前后的表達(dá)及臨床意義探討[J];中華放射腫瘤學(xué)雜志;2004年03期

9 閔華慶,洪明晃,郭翔,錢朝南;鼻咽癌研究進(jìn)展[J];中國腫瘤;1999年12期

10 楊紅枚,李文鑫,章小平,劉輝;足葉乙甙誘導(dǎo)的鼻咽癌細(xì)胞亞系共表達(dá)多藥耐藥相關(guān)蛋白和P-gp[J];中華醫(yī)學(xué)雜志;2000年02期

本文編號：2422515